Blood–brain barrier dysfunction in status epileptics: Mechanisms and role in epileptogenesis

Keyphrases

• Blood-brain Barrier Disruption 100%
• Epileptogenesis 100%
• Status Epileptics 100%
• Blood-brain Barrier 71%
• Transforming Growth Factor-β 28%
• Brain Injury 28%
• Neurovascular Unit 28%
• Status Epilepticus 28%
• Small Molecules 14%
• Astrocytes 14%
• Neuronal Firing 14%
• Clinical Trials 14%
• Microglia 14%
• Brain Regions 14%
• Central Nervous System 14%
• Synaptic Plasticity 14%
• Synaptogenesis 14%
• Signaling Pathway 14%
• Preclinical Data 14%
• Imaging Approach 14%
• Beta-blockers 14%
• Peripheral Circulation 14%
• Epileptic Syndromes 14%
• Neuronal Excitability 14%
• Flow Response 14%
• Pericytes 14%
• Neuroinflammation 14%
• Seizure Disorder 14%
• Losartan 14%
• Diagnostic Biomarker 14%
• Barrier Function 14%
• Cerebral Vessels 14%
• Astroglial 14%
• Serum Albumin 14%
• Seizure Threshold 14%
• Response to Injury 14%
• Neural Circuits 14%
• Pro-inflammatory Pathways 14%
• Predictive Biomarker 14%
• Neurovascular Dysfunction 14%
• Pharmacodynamic Biomarker 14%
• Blood Flow Regulation 14%
• Physiological Interface 14%
• Angiotensin Antagonists 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Epileptic State 100%
• Epileptogenesis 100%
• Brain Injury 50%
• Transforming Growth Factor Beta 50%
• Disease 25%
• Injury 25%
• Biological Marker 25%
• Clinical Trial 25%
• Extravasation 25%
• Losartan 25%
• Pharmacodynamics 25%
• Serum Albumin 25%
• Nervous System Inflammation 25%
• Angiotensin Antagonist 25%

Neuroscience

• Blood Brain Barrier 100%
• Epileptogenesis 100%
• Status Epilepticus 100%
• Transforming Growth Factor Beta 16%
• Astrocyte 8%
• Microglia 8%
• Synaptic Plasticity 8%
• Synaptogenesis 8%
• Central Nervous System 8%
• Cell Signaling 8%
• Excitability 8%
• Neural Circuit 8%
• Angiotensin 8%
• Epilepsy 8%
• Serum Albumin 8%
• Losartan 8%